Personal experience with hypoglycemic islet-cell neoplasms
Goffrini, P.; Peracchia, A.
L'Ateneo Parmense. Acta Bio-Medica Organo Della Societa di Medicina e Scienze Naturali di Parma 48(5): 543-544
1977
ISSN/ISBN: 1123-7325 PMID: 207290 Document Number: 114117
Document emailed within 1 workday
Related Documents
Yano, T.; Yamamoto, N.; Fujimori, K.; Inamori, S.; Hayashi, H.; Mizumoto, R. 1982: Glucagon-secreting pancreatic islet cell carcinoma, containing insulin and somatostatin, with hypoglycemic attack American Journal of Gastroenterology 77(6): 387-391Durruty, P.; García de los Rios, M.; López, G. 1988: Secondary failure to oral hypoglycemic drugs: islet cell function determined by urinary C-peptide Revista Medica de Chile 116(4): 301-307
Metrakos, P.; Yuan, S.; Agapitos, D.; Rosenberg, L. 1994: Paracrine signaling (duct-->islet) in the pancreas and maintenance of islet cell mass--potential implications for islet transplantation Transplantation Proceedings 26(2): 637-638
Miszka, K. 1995: Fronto-lateral laryngectomy in treatment of laryngeal neoplasms. Personal experience Otolaryngologia Polska 49(Suppl 20): 436-438
Mezzetti, M.; Calati, A.M.; Schubert, L. 2002: Positron emission-computed tomography in diagnosis and staging of lung neoplasms. Personal experience Minerva Chirurgica 57(4): 461-465
Bonifacio, E.; Lampasona, V.; Genovese, S.; Ferrari, M.; Bosi, E. 1995: Identification of protein tyrosine phosphatase-like IA2 (islet cell antigen 512) as the insulin-dependent diabetes-related 37/40K autoantigen and a target of islet-cell antibodies Journal of Immunology 155(11): 5419-5426
Shalimov, A.A.; Turchin, I.S.; Lifshits, I.Z.; Tishchenko, A.V.; Kozhara, S.P.; Usenko, A.Iu. 1990: Experience in xenografts of pancreatic islet cell cultures after surgical treatment of chronic pancreatitis Klinicheskaia Khirurgiia 11: 1-2
Vázquez, A.; Moya, G.; Ricoy, J.R. 1970: Neurological aspects of hypoglycemic coma; hypoglycemic comas of medical origin caused by hypoglycemic agents Revista Clinica Espanola 117(2): 157-168
Maruyama, S.; Sugiura, M.; Tomiyama, H.; Aizawa, T.; Ishido, T.; Kinjyo, T.; Kuwae, M.; Mimura, G. 1984: Detection of human circulating islet cell surface antibodies by dispersed rat pancreatic islet cells (III). Examination of clinical significance Rinsho Byori. Japanese Journal of Clinical Pathology 32(3): 291-298
Torres Lobatón, A.; Silva Pérez, E.; Mendoza Tenorio, A.; Romero Pinos, M. 1983: Malignant germ cell neoplasms of the ovary. Experience with 40 cases Ginecologia y Obstetricia de Mexico 51(318): 259-266
Bianchi, E.; Impagnatiello, M.A.; Inverardi, L.; Socci, C.; Di Carlo, V.; Pozza, G.; Pardi, R. 1995: A model of islet vascularization in vitro: contrasting metabolic effects of mixed islet/vascular cell cocultures on xenogeneic versus allogeneic vascular endothelium Transplantation Proceedings 27(6): 3341-3342
Ser, I. 1971: Clinical experience with glibenclamide, a new hypoglycemic agent Harefuah 81(8): 364-368
Hazard, J. 1976: Hypoglycemic complications induced by hypoglycemic sulfonamides. Recall of pharmacological basis of their therapeutic use La Nouvelle Presse Medicale 5(14): 903-905
Kunoh, Y.; Iguchi, A.; Gotoh, M.; Nomura, T.; Shibata, M.; Sakamoto, N. 1986: Hypoglycemic activity of MTP-1403 (2-amino-7,8-dihydro-4-piperazinyl-6H-thiopyrano 3,2-d pyrimidine), a new hypoglycemic agent Archives Internationales de Pharmacodynamie et de Therapie 280(2): 302-313
Merchant, P.C.; Godse, C.S.; Varthakavi, P.K.; Patel, K.L.; Nihalani, K.D. 1996: Prevalence of islet cell antibodies and B cell functional status in insulin dependent diabetes Journal of the Association of Physicians of India 44(7): 457-460
Rodríguez-Miñón, J.L.; Herrera Pombo, J.L.; Marrón, J.A. 1971: Clinical experience with RO 6-4563 (Glibornuride) (a new oral hypoglycemic agent) Revista Clinica Espanola 123(5): 439-442
Bosco, L.; Deotto, L.; Pederzoli, C.; Fossati, A.; Vergani, V.; Comi, L. 1981: Benign neoplasms of the stomach: personal cases Chirurgia Italiana 33(2): 542-553
Kunoh, Y.; Ogawa, H.; Nagasaka, M.; Asai, H.; Iguchi, A.; Niki, A.; Sakamoto, N. 1989: Pharmacological studies on the hypoglycemic effect of 7,8-dihydro-2-(4-methylpiperazinyl)-4-(1-pyrrolidinyl)-6H-thi opyrano [3,2-d] pyrimidine dimaleate (MTP-1307), a novel hypoglycemic agent Archives Internationales de Pharmacodynamie et de Therapie 298: 276-287
Accettella, U.; Sacra, A.; Gentile, M. 1970: Hypoglycemic attacks caused by oral hypoglycemic drugs Il Policlinico. Sezione Pratica 77(37): 1173-1178
Remiszewski, P.; Słodkowska, J.; Pawlicka, L.; Płodziszewska, M.; Załeska, J.; Dorosz, P.; Rowińska-Zakrzewska, E. 1998: Our experience in bronchiolitis obliterans organising pneumonia (BOOP): personal experience Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 5(30): 372-376